August 24, 2006 Cambridge Consultants today revealed an innovative medical device concept for managing diabetes that uses NFC, the close-proximity wireless communications standard, to integrate glucometers and insulin pumps. The prototype device, developed in conjunction with Philips, demonstrates how NFC can be exploited to simplify treatment for millions of diabetics worldwide, and could be the first of a new generation of medical devices that use close-proximity wireless communications. According to the World Health Organisation (WHO), diabetes is officially classified as a worldwide epidemic with the number of people with the disease to double to 366m by 2030. To tackle this growing global problem, the Cambridge Consultants concept device uses the unique characteristics of NFC to streamline treatment, by wirelessly linking a glucometer with an insulin pump. The glucometer records the blood sugar reading and then recommends a bolus dose of insulin. If the patient accepts the dose, then they simply swipe the glucometer against the insulin pump, which could be located beneath clothing, and the drug is delivered. This confirmation feature, which Cambridge Consultants dubs 'patient-in-the-loop dosing', enhances confidence and security, and allows the user to modify dosage calculations for lifestyle reasons.